Adjuvant atezolizumab does not improve outcomes for patients with RCC and increased risk of recurrence Presented ByDr Axel Bex, The Royal Free London NHS Foundation Trust, UK TrialPhase 3, IMmotion-010 ConferenceESMO 2022 17 November, 2022 00:28